Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of valproic acid in adults with bipolar disorder
ChiCTR1900025061Phase 4Not yet recruiting
- Sponsor
- Beijing Anding Hospital
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of valproic acid in bipolar disorder (BD), sponsored by Beijing Anding Hospital. Primary endpoint: Blood concentration of valproic acid. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
valproic acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on ChiCTR1900025061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025061.